nafld and glutathione Efficacy of for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study | BMC Gastroenterology Hepatocyte glutathione S-transferase mu 2
Description
224:jeb221606
[DOI] [PubMed] [Google Scholar] 91.Yang M.H., Ha I.J., Lee S., Lee J., Um J., Ahn K.S
For oral administration, mild gastrointestinal symptoms such as dyspepsia, nausea, vomiting, or diarrhea are the most common adverse effects [16,17]
Stop if you develop any concerning new symptoms suggesting malignancy (unexplained weight loss, persistent fevers, unusual lumps, persistent bleeding)
Finally, the absorbance was determined at a wavelength of 520 nm
